Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Medikaloka Hermina Tbk PT
IDX:HEAL
Medikaloka Hermina Tbk PT
IDX:HEAL
Price:
620
IDR
3.33%
Market Cap:
Rp9.5T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
ID |
|
X
|
Xcel Energy Inc
F:NRN
|
US |
|
A
|
Adaro Energy Indonesia TBK PT
SWB:A64
|
ID |
|
Aboitiz Power Corp
OTC:ABZPF
|
PH |
|
M
|
Morn Sun Feed Mill Corp
TPEX:1240
|
TW |
|
S
|
Sysco Corp
DUS:SYY
|
US |
|
P
|
Polylite Taiwan Co Ltd
TPEX:1813
|
TW |
|
Torq Resources Inc
XTSX:TORQ
|
CA |
|
D
|
Dollar General Corp
XMUN:7DG
|
US |
|
T
|
Topaz Energy Corp
TSX:TPZ
|
CA |
|
China Coal Energy Co Ltd
OTC:CCOZF
|
CN |
|
Arypsa Inc
OTC:APYI
|
US |
|
K
|
Klabin SA
BOVESPA:KLBN4
|
BR |
|
Shimano Inc
OTC:SHMDF
|
JP |
Wall St Price Targets
HEAL Price Forecast
Based on 13 analysts
Based on 13 analysts
+163% Upside
from
Rp620
today
Medikaloka Hermina Tbk PT (HEAL)’s 12-month stock price forecast through October 2027 has a consensus target of Rp1 632, implying 163% upside. The forecast is based on price targets from 13 Wall Street analysts.
HEAL Analyst Rating
No ratings yet
No ratings yet
Medikaloka Hermina Tbk PT Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HEAL's stock price target?
Price Target
1 632
IDR
1 632
IDR
According to Wall Street analysts, the average 1-year price target for HEAL is 1 632 IDR with a low forecast of 959.5 IDR and a high forecast of 1 869 IDR.
What is the Revenue forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
10%
10%
Over the last 9 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
9%
9%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
10%
10%
Over the last 9 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
16%
16%
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
16%
16%
Over the last 9 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 16%.